8 completed, 4 recruiting, 1 not yet recruiting. 8 Phase 1, 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 5 | Completed 2, Recruiting 2, Not yet recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow VC005 tablets: new trials by email Literature Review of VC005 tablets trials Research Report on VC005 tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo VC005 tablets - Non-Segmental Vitiligo | Phase 1 / Phase 2 | Not yet recruiting | Jiangsu vcare pharmaceutical technology co., LTD | 10 | 2026-09-25 | 2026-09-18 |
| A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata VC005 tablets - Alopecia Areata | Phase 1 | Recruiting | Jiangsu vcare pharmaceutical technology co., LTD | 24 | 2026-09-22 | 2026-10-20 |
| Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata Drug: VC005 tablets, VC005 tablets, VC005 placebo tablets - Alopecia Areata | Phase 2 | Recruiting | Jiangsu vcare pharmaceutical technology co., LTD | 120 | 2026-08-18 | 2026-08-27 |
| Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function VC005 Tablets - Renal Impairment | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 32 | 2026-05-09 | 2026-08-20 |
| Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function VC005 Tablets - Hepatic Impairment and Healthy Female | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 24 | 2026-04-29 | 2026-08-20 |
| A Food Effect Study of VC005 Tablets in Healthy Adult Subjects. VC005 Tablets - Atopic Dermatitis | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 31 | 2026-04-23 | 2026-06-08 |
| Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. VC005 tablets, VC005 Tablets Placebo - Active Ankylosing Spondylitis | Phase 3 | Recruiting | Jiangsu vcare pharmaceutical technology co., LTD | 420 | 2025-12-26 | 2026-01-02 |
| Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo VC005 tablets, VC005 Tablets Placebo - Non-segmental Vitiligo | Phase 2 | Recruiting | Jiangsu vcare pharmaceutical technology co., LTD | 120 | 2025-10-31 | 2026-01-02 |
| Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis VC005 tablets, VC005 Tablets Placebo - Moderate to Severe Atopic Dermatitis | Phase 2 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 149 | 2023-07-20 | 2024-07-29 |
| A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis. VC005 tablets, VC005 Tablets Placebo - Rheumatoid Arthritis | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 30 | 2023-06-12 | 2023-11-03 |
| Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. VC005 tablets, Tofacitinib Citrate Tablets, VC005 Tablets Placebo - Active Ankylosing Spondylitis | Phase 2 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 180 | 2023-04-26 | 2024-07-29 |
| Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects VC005 tablets, VC005 Placebo tablets - Inflammatory Bowel Diseases | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 60 | 2022-06-18 | 2022-11-17 |
| Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects VC005 Tablets, VC005 Tablets Placebo, VC005 Tablets food effects group - Inflammatory Bowel Diseases | Phase 1 | Completed | Jiangsu vcare pharmaceutical technology co., LTD | 78 | 2021-11-18 | 2022-09-02 |
Alopecia Areata (2) · Inflammatory Bowel Diseases (2) · Arthritis, Rheumatoid (1) · Dermatitis, Atopic (1) · Renal Insufficiency (1)
Jiangsu vcare pharmaceutical technology co., LTD (13)
China (13)
Huan Zhou (2) · Xu Liu (2) · Zhanguo Li (2) · Jianzhong Zhang (1) · Jianzhong Zhang Zhang (1) · Nanya Wang (1) · Qianjin Lu (1) · Yanhua Ding (1)